132 related articles for article (PubMed ID: 38746901)
1. Pyrrolidinone Derivatives as NIK Inhibitors for Treating Autoimmune and Inflammatory Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 May; 15(5):581-582. PubMed ID: 38746901
[TBL] [Abstract][Full Text] [Related]
2. Pyrrolidinone Derivatives as NIK Inhibitors for Treating Inflammatory and Autoimmune Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 Mar; 15(3):322-323. PubMed ID: 38505855
[TBL] [Abstract][Full Text] [Related]
3. Novel Fused Triazole Compounds as RIPK1 Inhibitors for Treating Neurodegenerative, Autoimmune, and Inflammatory Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 Feb; 15(2):177-178. PubMed ID: 38352847
[TBL] [Abstract][Full Text] [Related]
4. Novel Imidazotriazine Derivatives as IL-17 Modulators for Treating Inflammatory and Autoimmune Disorders.
Sabnis RW
ACS Med Chem Lett; 2023 May; 14(5):553-554. PubMed ID: 37197462
[TBL] [Abstract][Full Text] [Related]
5. TYK2 Inhibitors for Treating Autoimmune and Inflammatory Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 Mar; 15(3):320-321. PubMed ID: 38505839
[TBL] [Abstract][Full Text] [Related]
6. Novel Tyrosine Kinase 2 Inhibitors for Treating Autoimmune and Inflammatory Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 Jun; 15(6):769-770. PubMed ID: 38894908
[TBL] [Abstract][Full Text] [Related]
7. Novel Tetrahydropyrido[3,4-
Sabnis RW
ACS Med Chem Lett; 2024 Mar; 15(3):318-319. PubMed ID: 38505843
[TBL] [Abstract][Full Text] [Related]
8. Novel Pyrido[3,2-
Sabnis RW
ACS Med Chem Lett; 2023 Dec; 14(12):1627-1628. PubMed ID: 38116408
[TBL] [Abstract][Full Text] [Related]
9. Novel Thienopyrrole Compounds for Treating Autoimmune Diseases and Inflammatory Conditions.
Sabnis RW
ACS Med Chem Lett; 2023 May; 14(5):549-550. PubMed ID: 37197455
[TBL] [Abstract][Full Text] [Related]
10. Novel IRAK4 Inhibitors for Treating Asthma, COPD, Cancer, Autoinflammatory Diseases, and Autoimmune Diseases.
Sabnis RW
ACS Med Chem Lett; 2023 Dec; 14(12):1617-1618. PubMed ID: 38116447
[TBL] [Abstract][Full Text] [Related]
11. Boron-Containing Pyrazole Compounds as JAK Inhibitors for Treating Inflammation, Autoimmune Diseases, and Cancer.
Sabnis RW
ACS Med Chem Lett; 2022 Oct; 13(10):1554-1555. PubMed ID: 36267133
[TBL] [Abstract][Full Text] [Related]
12. Novel Pyrrole Derivatives as Apolipoprotein L-1 Inhibitors for Treating Kidney Diseases and Sepsis.
Sabnis RW
ACS Med Chem Lett; 2023 Dec; 14(12):1625-1626. PubMed ID: 38116414
[TBL] [Abstract][Full Text] [Related]
13. 1,2,4-Triazine Derivatives as NLRP3 Inhibitors for Treating Diseases.
Sabnis RW
ACS Med Chem Lett; 2023 May; 14(5):547-548. PubMed ID: 37197471
[TBL] [Abstract][Full Text] [Related]
14. Pyridazine Derivatives as NLRP3 Inhibitors for Treating Asthma, COPD, Parkinson's Disease, and Alzheimer's Disease.
Sabnis RW
ACS Med Chem Lett; 2023 Aug; 14(8):1047-1048. PubMed ID: 37583813
[TBL] [Abstract][Full Text] [Related]
15. Novel Myeloperoxidase Inhibitors for Treating Multiple Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 May; 15(5):569-570. PubMed ID: 38746891
[TBL] [Abstract][Full Text] [Related]
16. Novel Cyclopentathiophene Carboxamide Derivatives as PAFR Antagonists for Treating Ocular Diseases, Allergies, and Inflammation-Related Diseases.
Sabnis RW
ACS Med Chem Lett; 2023 Sep; 14(9):1148-1149. PubMed ID: 37736176
[TBL] [Abstract][Full Text] [Related]
17. Novel PCSK9 Inhibitors for Treating Cardiovascular Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 Apr; 15(4):443-444. PubMed ID: 38628783
[TBL] [Abstract][Full Text] [Related]
18. Novel HSD17B13 Inhibitors for Treating Liver Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 Jun; 15(6):771-772. PubMed ID: 38894932
[TBL] [Abstract][Full Text] [Related]
19. Novel Heterocyclic PAD4 Inhibitors for Treating Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 Mar; 15(3):340-341. PubMed ID: 38505857
[TBL] [Abstract][Full Text] [Related]
20. Novel Heterocyclic PAD4 Inhibitors for Treating Multiple Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 Feb; 15(2):179-180. PubMed ID: 38352837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
